Brief: Edesa Biotech Inc Entered Into An Exclusive License Agreement With Saul Yedgar

Edesa Biotech

22/03/2021 12:08

March 22 (Reuters) - Edesa Biotech Inc  EDSA.O :
    * EDESA BIOTECH INC -  ON MARCH 16, THROUGH UNIT, CO ENTERED
INTO
AN EXCLUSIVE LICENSE AGREEMENT WITH SAUL YEDGAR
    * EDESA BIOTECH INC - UNIT OBTAINED ADDITIONAL GLOBAL RIGHTS
TO A
PHARMACEUTICAL PRODUCT THAT FORMS BASIS OF EDESA'S EB01 AND EB02
DRUG CANDIDATES
    * EDESA - DUE TO DEAL ENTERED WITH LICENSOR, UNIT HOLDS
EXCLUSIVE
GLOBAL RIGHTS TO THE PHARMACEUTICAL PRODUCT FOR ALL FIELDS OF
USE IN HUMANS, ANIMALS
    * EDESA BIOTECH INC - UNIT IS IS COMMITTED TO PAYMENTS OF
VARIOUS
AMOUNTS TO LICENSOR UPON MEETING CERTAIN MILESTONES, UP TO ABOUT
$69.2 MILLION

Source text for Eikon: [https://bit.ly/3vYORns]
Further company coverage:  EDSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))